Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...

Patients were included if they underwent PCI and stent implantation in the LMCA because of stable CAD or acute coronary syndrome (ie, ST-segment–elevation myocardial infarction [STEMI], non-STEMI, and ...

Researchers say the data further support the use of an FFR-first strategy in treating intermediate coronary lesions.

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved ...

OCT seems to reduce periprocedural MI, a benefit not seen in the chronic coronary syndrome patients that deserves further ...

Discover 7 treatments for ischemic heart disease that are saving lives. From cutting-edge medications to advanced procedures ...

Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures - ...

Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVERtm Carotid Stent System. Indicated for use ...

University of Iowa Health Care has become the first in Iowa to offer drug-coated balloon therapy for patients with blockages ...

Deferred stenting shows no significant clinical benefits over conventional immediate percutaneous coronary intervention in ...